Structure

Physi-Chem Properties

Molecular Weight:  416.15
Volume:  400.789
LogP:  3.34
LogD:  3.437
LogS:  -4.836
# Rotatable Bonds:  5
TPSA:  84.84
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.797
Synthetic Accessibility Score:  3.992
Fsp3:  0.455
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.891
MDCK Permeability:  4.186553996987641e-05
Pgp-inhibitor:  0.077
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.001
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.055
Plasma Protein Binding (PPB):  96.40679931640625%
Volume Distribution (VD):  2.03
Pgp-substrate:  2.269899368286133%

ADMET: Metabolism

CYP1A2-inhibitor:  0.161
CYP1A2-substrate:  0.969
CYP2C19-inhibitor:  0.83
CYP2C19-substrate:  0.862
CYP2C9-inhibitor:  0.494
CYP2C9-substrate:  0.88
CYP2D6-inhibitor:  0.848
CYP2D6-substrate:  0.798
CYP3A4-inhibitor:  0.963
CYP3A4-substrate:  0.783

ADMET: Excretion

Clearance (CL):  12.445
Half-life (T1/2):  0.206

ADMET: Toxicity

hERG Blockers:  0.05
Human Hepatotoxicity (H-HT):  0.19
Drug-inuced Liver Injury (DILI):  0.556
AMES Toxicity:  0.036
Rat Oral Acute Toxicity:  0.016
Maximum Recommended Daily Dose:  0.337
Skin Sensitization:  0.698
Carcinogencity:  0.91
Eye Corrosion:  0.003
Eye Irritation:  0.059
Respiratory Toxicity:  0.255

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC56091

Natural Product ID:  NPC56091
Common Name*:   (2R,3R,4S)-4-[Bis(7-Methoxy-1,3-Benzodioxol-5-Yl)Methyl]-3-Methyloxolan-2-Ol
IUPAC Name:   (2R,3R,4S)-4-[bis(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3-methyloxolan-2-ol
Synonyms:  
Standard InCHIKey:  SNBUNJUZIKRKCA-MHLYXQECSA-N
Standard InCHI:  InChI=1S/C22H24O8/c1-11-14(8-26-22(11)23)19(12-4-15(24-2)20-17(6-12)27-9-29-20)13-5-16(25-3)21-18(7-13)28-10-30-21/h4-7,11,14,19,22-23H,8-10H2,1-3H3/t11-,14-,22-/m1/s1
SMILES:  C[C@@H]1[C@@H](CO[C@H]1O)C(c1cc(c2c(c1)OCO2)OC)c1cc(c2c(c1)OCO2)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL496846
PubChem CID:   11704381
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000296] Benzodioxoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28014 Garcinia gaudichaudii Species Clusiaceae Eukaryota n.a. bark n.a. PMID[11101460]
NPO27888 Sarcococca saligna Species Buxaceae Eukaryota n.a. n.a. n.a. PMID[14584959]
NPO27888 Sarcococca saligna Species Buxaceae Eukaryota n.a. n.a. n.a. PMID[14643329]
NPO27718 Peperomia dindygulensis Species Piperaceae Eukaryota whole plant Yunnan Province, China 2002-FEB PMID[16309318]
NPO27718 Peperomia dindygulensis Species Piperaceae Eukaryota whole plant Yunnan Province, China 2002-FEB PMID[16724842]
NPO27888 Sarcococca saligna Species Buxaceae Eukaryota n.a. n.a. n.a. PMID[9548847]
NPO27842 Gentiana makinoi Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO27888 Sarcococca saligna Species Buxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16710 Pandanus tectorius Species Pandanaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO27888 Sarcococca saligna Species Buxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO27842 Gentiana makinoi Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16710 Pandanus tectorius Species Pandanaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28014 Garcinia gaudichaudii Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16710 Pandanus tectorius Species Pandanaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO27842 Gentiana makinoi Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27888 Sarcococca saligna Species Buxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13728 Metanarthecium luteoviride Species Nartheciaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22405 Litsea monopetala Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO19590 Daedaleopsis tricolor Species Coriolaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16710 Pandanus tectorius Species Pandanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27184 Bonellia macrocarpa Species Primulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27718 Peperomia dindygulensis Species Piperaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27953 Eugenia formosa Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27401 Aniba riparia Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO17271 Aegialitis annulata Species Plumbaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27135 Tubularia larynx Species Tubulariidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27362 Hypericum elodes Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28066 Aloe speciosa Species Xanthorrhoeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28014 Garcinia gaudichaudii Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28133 Geigeria filifolia Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27439 Letharia vulpina Species Parmeliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1475 Cell Line WI-38 VA13 Homo sapiens IC50 = 138000.0 nM PMID[533249]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 140000.0 nM PMID[533249]
NPT27 Others Unspecified IC50 = 142000.0 nM PMID[533249]
NPT2 Others Unspecified Activity = 99.0 % PMID[533249]
NPT2 Others Unspecified Activity = 104.0 % PMID[533249]
NPT2 Others Unspecified Activity = 107.0 % PMID[533249]
NPT2 Others Unspecified Activity = 93.0 % PMID[533249]
NPT2 Others Unspecified Activity = 90.0 % PMID[533249]
NPT2 Others Unspecified Activity = 71.0 % PMID[533249]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC56091 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.985 High Similarity NPC46591
0.9848 High Similarity NPC283949
0.9701 High Similarity NPC226547
0.9699 High Similarity NPC185908
0.9697 High Similarity NPC150534
0.9562 High Similarity NPC166884
0.9562 High Similarity NPC477701
0.9562 High Similarity NPC141569
0.9549 High Similarity NPC236522
0.9549 High Similarity NPC148893
0.9549 High Similarity NPC49235
0.9549 High Similarity NPC25333
0.9489 High Similarity NPC185071
0.9489 High Similarity NPC12728
0.9474 High Similarity NPC31530
0.9416 High Similarity NPC287124
0.9403 High Similarity NPC189474
0.9398 High Similarity NPC196937
0.9348 High Similarity NPC298317
0.9348 High Similarity NPC255566
0.9338 High Similarity NPC113550
0.9328 High Similarity NPC47181
0.9323 High Similarity NPC72046
0.9323 High Similarity NPC65183
0.9323 High Similarity NPC261812
0.927 High Similarity NPC177868
0.9265 High Similarity NPC469981
0.9259 High Similarity NPC18576
0.9254 High Similarity NPC266848
0.9254 High Similarity NPC136750
0.9248 High Similarity NPC192255
0.9203 High Similarity NPC471908
0.9203 High Similarity NPC312199
0.9191 High Similarity NPC11453
0.9191 High Similarity NPC121651
0.9173 High Similarity NPC134764
0.9173 High Similarity NPC171550
0.9155 High Similarity NPC248132
0.9155 High Similarity NPC130449
0.9149 High Similarity NPC212890
0.9143 High Similarity NPC472712
0.9143 High Similarity NPC472713
0.9143 High Similarity NPC118385
0.9143 High Similarity NPC187774
0.9143 High Similarity NPC473046
0.9124 High Similarity NPC474039
0.9104 High Similarity NPC82111
0.9104 High Similarity NPC227160
0.9097 High Similarity NPC164082
0.9091 High Similarity NPC95392
0.9091 High Similarity NPC51328
0.9091 High Similarity NPC35877
0.9091 High Similarity NPC55715
0.9091 High Similarity NPC286235
0.9091 High Similarity NPC55158
0.9078 High Similarity NPC475868
0.9078 High Similarity NPC477702
0.9071 High Similarity NPC474808
0.9058 High Similarity NPC88640
0.9058 High Similarity NPC9068
0.9058 High Similarity NPC193666
0.9058 High Similarity NPC123526
0.9058 High Similarity NPC156376
0.9037 High Similarity NPC219671
0.9037 High Similarity NPC259742
0.9037 High Similarity NPC147616
0.9037 High Similarity NPC104077
0.903 High Similarity NPC233224
0.903 High Similarity NPC271208
0.9023 High Similarity NPC54321
0.9023 High Similarity NPC328682
0.9023 High Similarity NPC281864
0.9007 High Similarity NPC172171
0.9007 High Similarity NPC239254
0.9 High Similarity NPC311057
0.9 High Similarity NPC474295
0.9 High Similarity NPC5262
0.9 High Similarity NPC246947
0.9 High Similarity NPC472714
0.8986 High Similarity NPC101807
0.8978 High Similarity NPC24490
0.8978 High Similarity NPC141765
0.8978 High Similarity NPC165155
0.8978 High Similarity NPC34103
0.8971 High Similarity NPC1474
0.8958 High Similarity NPC240521
0.8958 High Similarity NPC477698
0.8951 High Similarity NPC39657
0.8947 High Similarity NPC473092
0.8947 High Similarity NPC158737
0.8947 High Similarity NPC473093
0.8947 High Similarity NPC8050
0.8944 High Similarity NPC180953
0.8936 High Similarity NPC477898
0.8936 High Similarity NPC324962
0.8913 High Similarity NPC25695
0.8913 High Similarity NPC143895
0.8913 High Similarity NPC197166
0.8913 High Similarity NPC172818
0.8905 High Similarity NPC326095
0.8905 High Similarity NPC244983
0.8897 High Similarity NPC473989
0.8897 High Similarity NPC238140
0.8897 High Similarity NPC100223
0.8897 High Similarity NPC129687
0.8897 High Similarity NPC171928
0.8897 High Similarity NPC33611
0.8897 High Similarity NPC16830
0.8897 High Similarity NPC158526
0.8897 High Similarity NPC7744
0.8889 High Similarity NPC270751
0.8889 High Similarity NPC63574
0.8881 High Similarity NPC226862
0.8881 High Similarity NPC165128
0.8881 High Similarity NPC222127
0.8881 High Similarity NPC158471
0.8881 High Similarity NPC57119
0.8881 High Similarity NPC82862
0.8873 High Similarity NPC84181
0.8873 High Similarity NPC92693
0.8873 High Similarity NPC179521
0.8873 High Similarity NPC218841
0.8872 High Similarity NPC40352
0.8872 High Similarity NPC213711
0.8865 High Similarity NPC230538
0.8865 High Similarity NPC103637
0.8865 High Similarity NPC36531
0.8865 High Similarity NPC229172
0.8857 High Similarity NPC216434
0.8857 High Similarity NPC103448
0.8841 High Similarity NPC101624
0.8841 High Similarity NPC126409
0.8841 High Similarity NPC142547
0.8841 High Similarity NPC135777
0.8841 High Similarity NPC184938
0.8841 High Similarity NPC99572
0.8841 High Similarity NPC474139
0.8841 High Similarity NPC174191
0.8832 High Similarity NPC58585
0.8832 High Similarity NPC169973
0.8832 High Similarity NPC69513
0.8832 High Similarity NPC215833
0.8819 High Similarity NPC116019
0.8811 High Similarity NPC22150
0.8811 High Similarity NPC205316
0.8811 High Similarity NPC279298
0.8811 High Similarity NPC38041
0.8811 High Similarity NPC469586
0.8803 High Similarity NPC265154
0.8794 High Similarity NPC472711
0.8786 High Similarity NPC290714
0.8786 High Similarity NPC201404
0.8786 High Similarity NPC6369
0.8786 High Similarity NPC53722
0.8786 High Similarity NPC30951
0.8777 High Similarity NPC32189
0.8776 High Similarity NPC56184
0.8768 High Similarity NPC287745
0.8768 High Similarity NPC48863
0.8768 High Similarity NPC107478
0.8768 High Similarity NPC13745
0.8768 High Similarity NPC251981
0.8767 High Similarity NPC472710
0.8767 High Similarity NPC472709
0.8759 High Similarity NPC204215
0.8759 High Similarity NPC316676
0.8759 High Similarity NPC71726
0.8759 High Similarity NPC175067
0.8759 High Similarity NPC325720
0.875 High Similarity NPC154971
0.875 High Similarity NPC193779
0.875 High Similarity NPC205796
0.875 High Similarity NPC252286
0.875 High Similarity NPC276753
0.875 High Similarity NPC112861
0.8741 High Similarity NPC191158
0.8741 High Similarity NPC177644
0.8741 High Similarity NPC473045
0.8741 High Similarity NPC25292
0.8732 High Similarity NPC472562
0.8732 High Similarity NPC80326
0.8732 High Similarity NPC151423
0.8732 High Similarity NPC302506
0.8732 High Similarity NPC189115
0.8732 High Similarity NPC40237
0.8731 High Similarity NPC50683
0.8731 High Similarity NPC88297
0.8731 High Similarity NPC473960
0.8731 High Similarity NPC112571
0.8731 High Similarity NPC9891
0.8731 High Similarity NPC186845
0.8731 High Similarity NPC206882
0.8731 High Similarity NPC285725
0.8723 High Similarity NPC284464
0.8699 High Similarity NPC174512
0.8699 High Similarity NPC474965
0.8699 High Similarity NPC477695
0.8699 High Similarity NPC668
0.8699 High Similarity NPC293757
0.8696 High Similarity NPC112237

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC56091 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8543 High Similarity NPD4967 Phase 2
0.8543 High Similarity NPD4966 Approved
0.8543 High Similarity NPD4965 Approved
0.8406 Intermediate Similarity NPD3027 Phase 3
0.8358 Intermediate Similarity NPD3705 Approved
0.8344 Intermediate Similarity NPD37 Approved
0.8312 Intermediate Similarity NPD6234 Discontinued
0.8176 Intermediate Similarity NPD7228 Approved
0.8089 Intermediate Similarity NPD7199 Phase 2
0.7975 Intermediate Similarity NPD7240 Approved
0.7875 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7847 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7847 Intermediate Similarity NPD1613 Approved
0.7842 Intermediate Similarity NPD2983 Phase 2
0.7842 Intermediate Similarity NPD2982 Phase 2
0.782 Intermediate Similarity NPD5283 Phase 1
0.7785 Intermediate Similarity NPD6674 Discontinued
0.777 Intermediate Similarity NPD2981 Phase 2
0.7746 Intermediate Similarity NPD3018 Phase 2
0.7746 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7737 Intermediate Similarity NPD1357 Approved
0.7697 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD3818 Discontinued
0.7613 Intermediate Similarity NPD1653 Approved
0.7569 Intermediate Similarity NPD4908 Phase 1
0.7562 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD7266 Discontinued
0.7466 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD1610 Phase 2
0.7447 Intermediate Similarity NPD1091 Approved
0.7438 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD7074 Phase 3
0.7412 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD7054 Approved
0.7342 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD4005 Discontinued
0.7333 Intermediate Similarity NPD7680 Approved
0.7321 Intermediate Similarity NPD7472 Approved
0.731 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD1375 Discontinued
0.7303 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD5058 Phase 3
0.726 Intermediate Similarity NPD2861 Phase 2
0.7248 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD3620 Phase 2
0.723 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4749 Approved
0.7208 Intermediate Similarity NPD4237 Approved
0.7208 Intermediate Similarity NPD4236 Phase 3
0.7194 Intermediate Similarity NPD7157 Approved
0.7193 Intermediate Similarity NPD7808 Phase 3
0.719 Intermediate Similarity NPD3540 Phase 1
0.7179 Intermediate Similarity NPD7124 Phase 2
0.7176 Intermediate Similarity NPD6797 Phase 2
0.7171 Intermediate Similarity NPD4108 Discontinued
0.7163 Intermediate Similarity NPD1548 Phase 1
0.716 Intermediate Similarity NPD2978 Approved
0.716 Intermediate Similarity NPD2977 Approved
0.7153 Intermediate Similarity NPD228 Approved
0.7135 Intermediate Similarity NPD6559 Discontinued
0.7135 Intermediate Similarity NPD7251 Discontinued
0.7134 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD3539 Phase 1
0.7117 Intermediate Similarity NPD3817 Phase 2
0.7115 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD6111 Discontinued
0.7101 Intermediate Similarity NPD7843 Approved
0.7099 Intermediate Similarity NPD1934 Approved
0.7099 Intermediate Similarity NPD3383 Approved
0.7099 Intermediate Similarity NPD3382 Approved
0.7099 Intermediate Similarity NPD3384 Approved
0.7093 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD7028 Phase 2
0.7081 Intermediate Similarity NPD4678 Approved
0.7081 Intermediate Similarity NPD4675 Approved
0.7073 Intermediate Similarity NPD3882 Suspended
0.7073 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD5126 Approved
0.7063 Intermediate Similarity NPD5125 Phase 3
0.7059 Intermediate Similarity NPD2684 Approved
0.7055 Intermediate Similarity NPD5563 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD4110 Phase 3
0.7051 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD3892 Phase 2
0.7048 Intermediate Similarity NPD5494 Approved
0.7047 Intermediate Similarity NPD4625 Phase 3
0.7035 Intermediate Similarity NPD7685 Pre-registration
0.7025 Intermediate Similarity NPD4357 Discontinued
0.702 Intermediate Similarity NPD4060 Phase 1
0.7007 Intermediate Similarity NPD3021 Approved
0.7007 Intermediate Similarity NPD3022 Approved
0.6989 Remote Similarity NPD6842 Approved
0.6989 Remote Similarity NPD6841 Approved
0.6989 Remote Similarity NPD6843 Phase 3
0.6987 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6986 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6166 Phase 2
0.6982 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6974 Remote Similarity NPD5735 Approved
0.6972 Remote Similarity NPD5536 Phase 2
0.6964 Remote Similarity NPD6232 Discontinued
0.6959 Remote Similarity NPD5844 Phase 1
0.6951 Remote Similarity NPD2801 Approved
0.6951 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6951 Remote Similarity NPD8455 Phase 2
0.6948 Remote Similarity NPD5588 Approved
0.6943 Remote Similarity NPD6331 Phase 2
0.6941 Remote Similarity NPD7473 Discontinued
0.6937 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6908 Remote Similarity NPD2238 Phase 2
0.6903 Remote Similarity NPD2161 Phase 2
0.6899 Remote Similarity NPD2219 Phase 1
0.6887 Remote Similarity NPD5110 Phase 2
0.6887 Remote Similarity NPD5109 Approved
0.6887 Remote Similarity NPD5111 Phase 2
0.6883 Remote Similarity NPD4536 Approved
0.6883 Remote Similarity NPD4538 Approved
0.6883 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6879 Remote Similarity NPD3060 Approved
0.6879 Remote Similarity NPD5177 Phase 3
0.6871 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6863 Remote Similarity NPD3657 Discovery
0.6863 Remote Similarity NPD6355 Discontinued
0.686 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6859 Remote Similarity NPD5762 Approved
0.6859 Remote Similarity NPD5763 Approved
0.6855 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6832 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6826 Remote Similarity NPD4055 Discovery
0.6824 Remote Similarity NPD8651 Approved
0.6821 Remote Similarity NPD7095 Approved
0.6805 Remote Similarity NPD8127 Discontinued
0.6803 Remote Similarity NPD1608 Approved
0.68 Remote Similarity NPD7549 Discontinued
0.6798 Remote Similarity NPD7243 Clinical (unspecified phase)
0.6797 Remote Similarity NPD1558 Phase 1
0.6797 Remote Similarity NPD4140 Approved
0.6778 Remote Similarity NPD7296 Approved
0.6774 Remote Similarity NPD7097 Phase 1
0.6772 Remote Similarity NPD1652 Phase 2
0.677 Remote Similarity NPD4123 Phase 3
0.6768 Remote Similarity NPD4380 Phase 2
0.6765 Remote Similarity NPD7229 Phase 3
0.6765 Remote Similarity NPD3787 Discontinued
0.6763 Remote Similarity NPD4750 Phase 3
0.6757 Remote Similarity NPD3685 Discontinued
0.6755 Remote Similarity NPD5752 Clinical (unspecified phase)
0.6753 Remote Similarity NPD230 Phase 1
0.6753 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6753 Remote Similarity NPD5124 Phase 1
0.6748 Remote Similarity NPD4210 Discontinued
0.6747 Remote Similarity NPD1465 Phase 2
0.6747 Remote Similarity NPD7819 Suspended
0.6735 Remote Similarity NPD422 Phase 1
0.6732 Remote Similarity NPD1726 Clinical (unspecified phase)
0.6731 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6731 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6731 Remote Similarity NPD5960 Phase 3
0.673 Remote Similarity NPD4628 Phase 3
0.673 Remote Similarity NPD7466 Approved
0.6728 Remote Similarity NPD7526 Approved
0.6728 Remote Similarity NPD52 Approved
0.6728 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5604 Discontinued
0.6725 Remote Similarity NPD3926 Phase 2
0.6725 Remote Similarity NPD5242 Approved
0.6712 Remote Similarity NPD5846 Approved
0.6712 Remote Similarity NPD6516 Phase 2
0.671 Remote Similarity NPD6653 Approved
0.6709 Remote Similarity NPD970 Clinical (unspecified phase)
0.6708 Remote Similarity NPD1511 Approved
0.6707 Remote Similarity NPD7261 Clinical (unspecified phase)
0.6707 Remote Similarity NPD2563 Approved
0.6707 Remote Similarity NPD2560 Approved
0.6688 Remote Similarity NPD6099 Approved
0.6688 Remote Similarity NPD6100 Approved
0.6688 Remote Similarity NPD2438 Suspended
0.6687 Remote Similarity NPD2677 Approved
0.6687 Remote Similarity NPD6190 Approved
0.6686 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4162 Approved
0.6667 Remote Similarity NPD1242 Phase 1
0.6667 Remote Similarity NPD2532 Approved
0.6667 Remote Similarity NPD2533 Approved
0.6667 Remote Similarity NPD6895 Approved
0.6667 Remote Similarity NPD2534 Approved
0.6667 Remote Similarity NPD6896 Approved
0.6667 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6647 Remote Similarity NPD5773 Approved
0.6647 Remote Similarity NPD5772 Approved
0.6646 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6005 Phase 3
0.6646 Remote Similarity NPD6004 Phase 3
0.6646 Remote Similarity NPD6006 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data